en_US EN
en_US EN ko_KR KR
Home
Pipeline

Proprietary PipelinePH PHARMA

Our pipeline includes first-in-class / best-in-class
therapeutic agents for the aging population and unmet markets.

Project

Area

Indication

Preclinical

Phase I

Phase II

Phase III

  • Ophthalmology
  • Glaucoma
0%
  • Genetic Disease
  • AATD
0%
  • Liver Disease
  • NASH
0%
  • Inflammation
  • ARDS
    (COVID-19)
0%
  • Oncology
  • Cancer
0%

*Development continues at Peak Bio (from March 2022).